BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1596 related articles for article (PubMed ID: 24893135)

  • 1. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
    Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
    J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acromegaly: an endocrine society clinical practice guideline.
    Katznelson L; Laws ER; Melmed S; Molitch ME; Murad MH; Utz A; Wass JA;
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3933-51. PubMed ID: 25356808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.
    Plouin PF; Amar L; Dekkers OM; Fassnacht M; Gimenez-Roqueplo AP; Lenders JW; Lussey-Lepoutre C; Steichen O;
    Eur J Endocrinol; 2016 May; 174(5):G1-G10. PubMed ID: 27048283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.
    Funder JW; Carey RM; Mantero F; Murad MH; Reincke M; Shibata H; Stowasser M; Young WF
    J Clin Endocrinol Metab; 2016 May; 101(5):1889-916. PubMed ID: 26934393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.
    Funder JW; Carey RM; Fardella C; Gomez-Sanchez CE; Mantero F; Stowasser M; Young WF; Montori VM;
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3266-81. PubMed ID: 18552288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
    Schreiner F; Beuschlein F
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.
    Nieman LK; Biller BM; Findling JW; Murad MH; Newell-Price J; Savage MO; Tabarin A;
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2807-31. PubMed ID: 26222757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.
    Fischer A; Kloos S; Maccio U; Friemel J; Remde H; Fassnacht M; Pamporaki C; Eisenhofer G; Timmers HJLM; Robledo M; Fliedner SMJ; Wang K; Maurer J; Reul A; Zitzmann K; Bechmann N; Žygienė G; Richter S; Hantel C; Vetter D; Lehmann K; Mohr H; Pellegata NS; Ullrich M; Pietzsch J; Ziegler CG; Bornstein SR; Kroiss M; Reincke M; Pacak K; Grossman AB; Beuschlein F; Nölting S
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2676-2685. PubMed ID: 36946182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the management of pheochromocytoma and paraganglioma.
    Tanabe A; Naruse M
    Hypertens Res; 2020 Nov; 43(11):1141-1151. PubMed ID: 32778780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytomas and Hypertension.
    Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
    Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
    Lenders JWM; Kerstens MN; Amar L; Prejbisz A; Robledo M; Taieb D; Pacak K; Crona J; Zelinka T; Mannelli M; Deutschbein T; Timmers HJLM; Castinetti F; Dralle H; Widimský J; Gimenez-Roqueplo AP; Eisenhofer G
    J Hypertens; 2020 Aug; 38(8):1443-1456. PubMed ID: 32412940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phaeochromocytoma and paraganglioma].
    Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
    Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
    Jain A; Baracco R; Kapur G
    Pediatr Nephrol; 2020 Apr; 35(4):581-594. PubMed ID: 30603807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
    Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
    J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes.
    Pacak K; Clifton-Bligh R
    Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36883571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.
    Fishbein L; Del Rivero J; Else T; Howe JR; Asa SL; Cohen DL; Dahia PLM; Fraker DL; Goodman KA; Hope TA; Kunz PL; Perez K; Perrier ND; Pryma DA; Ryder M; Sasson AR; Soulen MC; Jimenez C
    Pancreas; 2021 Apr; 50(4):469-493. PubMed ID: 33939658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.
    Kuo MJM; Nazari MA; Jha A; Pacak K
    Front Endocrinol (Lausanne); 2022; 13():936178. PubMed ID: 35903274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phaeochromocytomas and functional paragangliomas: clinical management.
    Plouin PF; Amar L; Lepoutre C
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):933-41. PubMed ID: 21115162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.